Skip to content
  • ABOUT
  • AUTHOR GUIDELINES
  • AUTHORS/EDITORS
  • SUBSCRIPTIONS
  • CONTACT US
  • MY ACCOUNT
FacebookXLinkedInInstagram
MedWorks Media Logo MedWorks Media Logo MedWorks Media Logo
×
  • HOME
  • PSYCH. BULLETIN
    • LATEST ISSUE
    • BLACK BOOK OF DOSING & MONITORING
  • RATING SCALES
    • LICENSING INFORMATION
  • RESOURCES
    • PSYCHOTROPICS A-Z
    • PSYCHOPHARMACOLOGY 101
  • NEWS
  • Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil1 x $0.00
    C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology1 x $30.00
    Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder1 x $0.00
    Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder1 x $0.00
    Regina C. Casper, MD: How Useful Are Pharmacological Treatments in Eating Disorders?1 x $30.00
    Sexual Pain among Malaysian Women Receiving Antidepressant: A Comparison between Escitalopram and Fluoxetine
    Sexual Pain among Malaysian Women Receiving Antidepressant: A Comparison between Escitalopram and Fluoxetine1 x $30.00
    Can We Distinguish Anxiety From Depression?1 x $30.00
    View Cart
    Checkout
  1. Home
  2. Cart
CartMedWorks2015-01-23T07:24:01-08:00
“Can We Distinguish Anxiety From Depression?” has been added to your cart. View cart
Some items in your cart are discounted for members. Log in to claim them!

You Have 7 Items In Your Cart

Product Price Quantity Subtotal Remove
Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil
$0.00 1 $0.00 ×
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
$30.00 1 $30.00 ×
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
$0.00 1 $0.00 ×
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$0.00 1 $0.00 ×
Regina C. Casper, MD: How Useful Are Pharmacological Treatments in Eating Disorders?
$30.00 1 $30.00 ×
Sexual Pain among Malaysian Women Receiving Antidepressant: A Comparison between Escitalopram and Fluoxetine
Sexual Pain among Malaysian Women Receiving Antidepressant: A Comparison between Escitalopram and Fluoxetine
$30.00 1 $30.00 ×
Can We Distinguish Anxiety From Depression?
$30.00 1 $30.00 ×

Have A Promotional Code?

Cart totals

Subtotal $120.00
Total $120.00
Update cart Proceed to checkout

CONTACT US

58427 Joshua Lane
Yucca Valley CA 92284

‭+1 (917) 692-8000‬
support@medworksmedia.com
MedWorksMedia.com

Privacy Policy
Cookie Policy

Useful Links

About Us

Articles In Press

Author Guidelines

Authors and Editorial Advisors

Journal Supplements

Psychopharmacology 101

Psychopharmacology Bulletin

Psychotropics A-Z

Subscriptions

Recent Psychopharmacology Bulletin Articles

  • Pocket Reference Guide - The Black Book of Psychotropic Dosing and Monitoring - Digital PDF $30.00
  • Trends in Outpatient Buprenorphine Prescribing for Chronic Pain: A Retrospective Analysis Over 18 Months $30.00
  • Kuwait-Mental Illness Disability Scale (K-MIDS): A Proposal $30.00

Brain Science Blogs

  • Novel Blood Test Could Help Diagnose and Track Alzheimer’s April 10, 2025
  • New 48-Week Remission Data on Ingrezza for the Treatment of TD April 1, 2025
  • Efficacy of esketamine for perinatal depression January 17, 2025
Copyright 2025 MedWorks Media Inc | All Rights Reserved
FacebookXLinkedInInstagram
Page load link
Go to Top